Datasets:

WitnessDataFactory
/

oncology-1k

record_id stringlengths 36 36	domain stringclasses 1 value	category stringclasses 8 values	note_type stringclasses 5 values	patient_age int64 18 85	patient_gender stringclasses 3 values	primary_label stringclasses 6 values	labels dict	consensus_score float64 0.97 1	inter_annotator_agreement float64 0.9 1	macro_f1 float64 0.95 0.99	model_scores dict	passes_quality_gate bool 1 class	generation_method stringclasses 1 value	generated_at stringlengths 27 27	phi_present bool 1 class	hipaa_compliant bool 1 class
2ea4c112-96d1-4740-a65e-bcf0802edf61	oncology	Leukemia	Pathology Report	79	Female	follow_up	{ "category": "Leukemia", "confidence": 0.9774, "primary": "follow_up" }	0.9774	0.9685	0.9668	{ "llama3.3": 0.9843, "mistral": 0.9853, "qwen2.5": 0.9625 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.732007Z	false	true
43e29bf6-7e9a-4829-8465-5dd7c237f52b	oncology	Lung Cancer	Chemotherapy Order	46	Non-binary	prognosis	{ "category": "Lung Cancer", "confidence": 0.9741, "primary": "prognosis" }	0.9741	0.915	0.9603	{ "llama3.3": 0.9343, "mistral": 0.998, "qwen2.5": 0.9899 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.732199Z	false	true
eaa9f10a-0595-445f-92f1-f281f5e23eb0	oncology	Lymphoma	Surgical Note	85	Female	diagnosis	{ "category": "Lymphoma", "confidence": 0.986, "primary": "diagnosis" }	0.986	0.986	0.9752	{ "llama3.3": 0.9831, "mistral": 0.9824, "qwen2.5": 0.9926 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.732586Z	false	true
0bc38562-aa4a-4834-a0e2-0c9071d0c1d5	oncology	Pancreatic Cancer	Chemotherapy Order	42	Non-binary	follow_up	{ "category": "Pancreatic Cancer", "confidence": 0.9736, "primary": "follow_up" }	0.9736	0.9838	0.9636	{ "llama3.3": 0.9776, "mistral": 0.9659, "qwen2.5": 0.9771 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.732925Z	false	true
77a4e4e6-5d6e-4544-b036-2abfc50ab0f4	oncology	Prostate Cancer	Surgical Note	73	Female	prognosis	{ "category": "Prostate Cancer", "confidence": 0.9718, "primary": "prognosis" }	0.9718	0.9659	0.9603	{ "llama3.3": 0.9772, "mistral": 0.956, "qwen2.5": 0.9822 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733083Z	false	true
e0244b37-ddc8-47ce-a6ef-742d197b7621	oncology	Leukemia	Surgical Note	72	Non-binary	follow_up	{ "category": "Leukemia", "confidence": 0.9805, "primary": "follow_up" }	0.9805	0.9921	0.9658	{ "llama3.3": 0.977, "mistral": 0.981, "qwen2.5": 0.9834 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733236Z	false	true
35056523-39cd-44b1-92c9-fe283a271099	oncology	Colorectal Cancer	Chemotherapy Order	23	Non-binary	staging	{ "category": "Colorectal Cancer", "confidence": 0.9771, "primary": "staging" }	0.9771	0.9501	0.9646	{ "llama3.3": 0.9609, "mistral": 0.9704, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733472Z	false	true
0383d95d-90aa-4c45-98c5-c0b9e98040ef	oncology	Leukemia	Surgical Note	56	Non-binary	follow_up	{ "category": "Leukemia", "confidence": 0.992, "primary": "follow_up" }	0.992	0.9776	0.986	{ "llama3.3": 0.9943, "mistral": 0.9819, "qwen2.5": 0.9997 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733636Z	false	true
9bb87934-2704-4598-be75-b37d9ea74658	oncology	Leukemia	Surgical Note	60	Non-binary	staging	{ "category": "Leukemia", "confidence": 0.9852, "primary": "staging" }	0.9852	0.9518	0.977	{ "llama3.3": 0.9629, "mistral": 0.9927, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733793Z	false	true
0e2236df-2690-43db-af68-32c250c7c364	oncology	Breast Cancer	Surgical Note	63	Non-binary	treatment_plan	{ "category": "Breast Cancer", "confidence": 0.9788, "primary": "treatment_plan" }	0.9788	0.9707	0.9588	{ "llama3.3": 0.9732, "mistral": 0.9925, "qwen2.5": 0.9706 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.733946Z	false	true
2012a977-ae3e-476a-ba6f-018ac5b2f414	oncology	Lung Cancer	Oncology Consultation	38	Male	follow_up	{ "category": "Lung Cancer", "confidence": 0.9841, "primary": "follow_up" }	0.9841	0.9786	0.9779	{ "llama3.3": 0.9827, "mistral": 0.9762, "qwen2.5": 0.9935 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.734331Z	false	true
6147a602-d845-42ff-9ce2-6fa8bcadbeab	oncology	Breast Cancer	Surgical Note	24	Male	follow_up	{ "category": "Breast Cancer", "confidence": 0.9864, "primary": "follow_up" }	0.9864	0.964	0.9744	{ "llama3.3": 0.9981, "mistral": 0.9699, "qwen2.5": 0.9912 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.734547Z	false	true
63c68cd6-4521-4f8b-bed6-c3f73d655001	oncology	Breast Cancer	Chemotherapy Order	80	Female	staging	{ "category": "Breast Cancer", "confidence": 0.9754, "primary": "staging" }	0.9754	0.9653	0.9584	{ "llama3.3": 0.9633, "mistral": 0.991, "qwen2.5": 0.9721 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.735008Z	false	true
22a50bd9-0282-4cae-9d22-c068e4586c52	oncology	Prostate Cancer	Oncology Consultation	32	Non-binary	adverse_event	{ "category": "Prostate Cancer", "confidence": 0.9859, "primary": "adverse_event" }	0.9859	0.983	0.9763	{ "llama3.3": 0.978, "mistral": 0.9911, "qwen2.5": 0.9885 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.735160Z	false	true
85d3790c-a475-4e8a-b521-5756a362dc41	oncology	Pancreatic Cancer	Radiation Plan	40	Female	treatment_plan	{ "category": "Pancreatic Cancer", "confidence": 0.9706, "primary": "treatment_plan" }	0.9706	0.9547	0.9518	{ "llama3.3": 0.9717, "mistral": 0.9516, "qwen2.5": 0.9885 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.735787Z	false	true
87f5dfa7-be3a-415b-835e-6f1b7ac1cee9	oncology	Melanoma	Radiation Plan	45	Female	adverse_event	{ "category": "Melanoma", "confidence": 0.9747, "primary": "adverse_event" }	0.9747	0.9842	0.9676	{ "llama3.3": 0.9759, "mistral": 0.9677, "qwen2.5": 0.9805 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.735953Z	false	true
81597e6f-1af5-4b22-a429-a4287e1cd45c	oncology	Prostate Cancer	Oncology Consultation	45	Female	follow_up	{ "category": "Prostate Cancer", "confidence": 0.9879, "primary": "follow_up" }	0.9879	0.9662	0.9704	{ "llama3.3": 0.9909, "mistral": 0.9729, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.736178Z	false	true
40e04171-d552-4dc7-834a-e9055fa20a95	oncology	Lymphoma	Pathology Report	54	Female	adverse_event	{ "category": "Lymphoma", "confidence": 0.9817, "primary": "adverse_event" }	0.9817	0.9764	0.9746	{ "llama3.3": 0.9838, "mistral": 0.9712, "qwen2.5": 0.9901 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.736433Z	false	true
60471b8c-06b5-4225-b77b-4000f614a115	oncology	Melanoma	Oncology Consultation	44	Non-binary	follow_up	{ "category": "Melanoma", "confidence": 0.9846, "primary": "follow_up" }	0.9846	0.953	0.9739	{ "llama3.3": 0.9907, "mistral": 1, "qwen2.5": 0.9631 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.736932Z	false	true
0a6dda71-06a7-4ce2-b465-5cc5a7616c1d	oncology	Leukemia	Oncology Consultation	22	Non-binary	prognosis	{ "category": "Leukemia", "confidence": 0.9883, "primary": "prognosis" }	0.9883	0.9684	0.9687	{ "llama3.3": 1, "mistral": 0.9904, "qwen2.5": 0.9745 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.737084Z	false	true
850284b4-cc32-4a2a-a7c3-ca3a4909c756	oncology	Lung Cancer	Radiation Plan	72	Male	staging	{ "category": "Lung Cancer", "confidence": 0.9765, "primary": "staging" }	0.9765	0.9832	0.965	{ "llama3.3": 0.9812, "mistral": 0.9796, "qwen2.5": 0.9686 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.737238Z	false	true
4671e830-c2f7-40d9-b8f5-881ad78ba3a1	oncology	Lung Cancer	Chemotherapy Order	36	Female	diagnosis	{ "category": "Lung Cancer", "confidence": 0.978, "primary": "diagnosis" }	0.978	0.9718	0.9585	{ "llama3.3": 0.9699, "mistral": 0.9729, "qwen2.5": 0.9912 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.737779Z	false	true
14ef43bd-2b43-4c89-bdc4-be783b19a471	oncology	Melanoma	Surgical Note	43	Male	staging	{ "category": "Melanoma", "confidence": 0.9875, "primary": "staging" }	0.9875	0.9728	0.981	{ "llama3.3": 0.9837, "mistral": 0.9788, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.738577Z	false	true
9af7b1ce-6057-4fc6-bf0f-6364089acae1	oncology	Prostate Cancer	Chemotherapy Order	18	Female	staging	{ "category": "Prostate Cancer", "confidence": 0.9777, "primary": "staging" }	0.9777	0.9841	0.9579	{ "llama3.3": 0.9718, "mistral": 0.9768, "qwen2.5": 0.9847 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.739060Z	false	true
db22e238-20e4-4c70-8494-ba94ff7cc65e	oncology	Leukemia	Pathology Report	51	Male	treatment_plan	{ "category": "Leukemia", "confidence": 0.9795, "primary": "treatment_plan" }	0.9795	0.9507	0.9638	{ "llama3.3": 0.9598, "mistral": 1, "qwen2.5": 0.9788 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.739215Z	false	true
03c29cdc-f6f6-4dc2-a832-10483265de21	oncology	Breast Cancer	Radiation Plan	76	Female	diagnosis	{ "category": "Breast Cancer", "confidence": 0.9886, "primary": "diagnosis" }	0.9886	0.9756	0.975	{ "llama3.3": 0.9844, "mistral": 1, "qwen2.5": 0.9815 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.739443Z	false	true
68485bc5-341b-4faa-95a3-ab51796823da	oncology	Breast Cancer	Oncology Consultation	24	Non-binary	prognosis	{ "category": "Breast Cancer", "confidence": 0.976, "primary": "prognosis" }	0.976	0.9906	0.964	{ "llama3.3": 0.9741, "mistral": 0.9735, "qwen2.5": 0.9804 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.740086Z	false	true
e18f5468-12fc-471a-95b8-adc8d7f5015c	oncology	Prostate Cancer	Pathology Report	36	Female	adverse_event	{ "category": "Prostate Cancer", "confidence": 0.9706, "primary": "adverse_event" }	0.9706	0.9525	0.9545	{ "llama3.3": 0.9869, "mistral": 0.9492, "qwen2.5": 0.9758 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.740300Z	false	true
a8939ec9-7d9f-4552-a6ed-8fee645b9a3d	oncology	Lung Cancer	Radiation Plan	45	Female	diagnosis	{ "category": "Lung Cancer", "confidence": 0.9899, "primary": "diagnosis" }	0.9899	0.9661	0.9734	{ "llama3.3": 0.9741, "mistral": 0.9955, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.740508Z	false	true
b4652273-9c19-4121-9e99-62555ca95267	oncology	Melanoma	Oncology Consultation	38	Male	follow_up	{ "category": "Melanoma", "confidence": 0.9758, "primary": "follow_up" }	0.9758	0.9623	0.9567	{ "llama3.3": 0.9593, "mistral": 0.9897, "qwen2.5": 0.9786 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.740669Z	false	true
44c42caa-2411-4322-aa84-04698ef9a70c	oncology	Prostate Cancer	Chemotherapy Order	20	Female	treatment_plan	{ "category": "Prostate Cancer", "confidence": 0.9807, "primary": "treatment_plan" }	0.9807	0.9574	0.9646	{ "llama3.3": 0.9769, "mistral": 0.9655, "qwen2.5": 0.9997 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.740833Z	false	true
92541c03-1c9c-4aa8-a301-95808629935e	oncology	Lung Cancer	Oncology Consultation	49	Non-binary	follow_up	{ "category": "Lung Cancer", "confidence": 0.9834, "primary": "follow_up" }	0.9834	0.964	0.9697	{ "llama3.3": 1, "mistral": 0.9721, "qwen2.5": 0.978 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.741145Z	false	true
6b232ad5-e8af-43e6-bdb2-2139db18c36a	oncology	Pancreatic Cancer	Pathology Report	74	Female	prognosis	{ "category": "Pancreatic Cancer", "confidence": 0.9717, "primary": "prognosis" }	0.9717	0.9821	0.9599	{ "llama3.3": 0.9789, "mistral": 0.9643, "qwen2.5": 0.9719 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.741357Z	false	true
5d7e3c83-0fc8-475e-b2fb-a9987ee5e686	oncology	Lung Cancer	Oncology Consultation	29	Female	prognosis	{ "category": "Lung Cancer", "confidence": 0.9829, "primary": "prognosis" }	0.9829	0.9749	0.967	{ "llama3.3": 0.9722, "mistral": 0.9838, "qwen2.5": 0.9927 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.741697Z	false	true
a16ef6e8-9e93-4679-afd2-26a4998fd31e	oncology	Lung Cancer	Oncology Consultation	35	Female	treatment_plan	{ "category": "Lung Cancer", "confidence": 0.9701, "primary": "treatment_plan" }	0.9701	0.9616	0.9635	{ "llama3.3": 0.9782, "mistral": 0.952, "qwen2.5": 0.9801 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.742013Z	false	true
01e2749b-fa57-44c9-98c8-8a8c328a7909	oncology	Prostate Cancer	Oncology Consultation	50	Non-binary	follow_up	{ "category": "Prostate Cancer", "confidence": 0.9836, "primary": "follow_up" }	0.9836	0.9505	0.9746	{ "llama3.3": 0.9603, "mistral": 0.9949, "qwen2.5": 0.9956 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.742170Z	false	true
1dc21c08-e63b-4367-afb0-caf196166300	oncology	Breast Cancer	Pathology Report	60	Non-binary	prognosis	{ "category": "Breast Cancer", "confidence": 0.978, "primary": "prognosis" }	0.978	0.9655	0.9716	{ "llama3.3": 0.9659, "mistral": 0.9935, "qwen2.5": 0.9747 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.742391Z	false	true
2ce67291-8568-4cc9-89b6-029731d300cf	oncology	Lymphoma	Pathology Report	18	Female	prognosis	{ "category": "Lymphoma", "confidence": 0.9764, "primary": "prognosis" }	0.9764	0.983	0.9667	{ "llama3.3": 0.9728, "mistral": 0.9719, "qwen2.5": 0.9844 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.742562Z	false	true
5575e0f2-a4cf-45f0-8e11-f8c27de97ddd	oncology	Colorectal Cancer	Pathology Report	34	Female	staging	{ "category": "Colorectal Cancer", "confidence": 0.9876, "primary": "staging" }	0.9876	0.9689	0.9761	{ "llama3.3": 0.9883, "mistral": 1, "qwen2.5": 0.9746 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.742747Z	false	true
1413c05d-cadf-4195-a20d-e548418e6b86	oncology	Lung Cancer	Pathology Report	65	Male	adverse_event	{ "category": "Lung Cancer", "confidence": 0.9874, "primary": "adverse_event" }	0.9874	0.9877	0.9726	{ "llama3.3": 0.9924, "mistral": 0.9824, "qwen2.5": 0.9875 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.743154Z	false	true
52c5679c-c8f3-45b2-9511-f3ea93623af4	oncology	Lymphoma	Oncology Consultation	63	Female	adverse_event	{ "category": "Lymphoma", "confidence": 0.9772, "primary": "adverse_event" }	0.9772	0.9514	0.9695	{ "llama3.3": 0.9644, "mistral": 0.9671, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.743386Z	false	true
bf8c8b8f-a26a-410d-bde1-53e711f65464	oncology	Breast Cancer	Chemotherapy Order	48	Female	diagnosis	{ "category": "Breast Cancer", "confidence": 0.9871, "primary": "diagnosis" }	0.9871	0.9836	0.973	{ "llama3.3": 0.9897, "mistral": 0.9921, "qwen2.5": 0.9795 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.743563Z	false	true
a8b05483-b2b1-468d-892b-dd68a1eb8502	oncology	Prostate Cancer	Radiation Plan	23	Non-binary	diagnosis	{ "category": "Prostate Cancer", "confidence": 0.9759, "primary": "diagnosis" }	0.9759	0.9914	0.9669	{ "llama3.3": 0.9719, "mistral": 0.9779, "qwen2.5": 0.978 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.743719Z	false	true
9d2fbad4-853a-4b95-b049-4426f9e01b75	oncology	Pancreatic Cancer	Surgical Note	82	Non-binary	prognosis	{ "category": "Pancreatic Cancer", "confidence": 0.9876, "primary": "prognosis" }	0.9876	0.9755	0.9721	{ "llama3.3": 0.9818, "mistral": 0.9991, "qwen2.5": 0.9818 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.743872Z	false	true
f1cfe2f9-344f-464d-b13a-1218d997a087	oncology	Leukemia	Chemotherapy Order	54	Male	follow_up	{ "category": "Leukemia", "confidence": 0.9846, "primary": "follow_up" }	0.9846	0.9544	0.9774	{ "llama3.3": 0.9954, "mistral": 0.9631, "qwen2.5": 0.9954 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.744178Z	false	true
936bcd69-9aa9-4606-be7c-c0f1ad55f5a5	oncology	Leukemia	Surgical Note	28	Male	prognosis	{ "category": "Leukemia", "confidence": 0.9935, "primary": "prognosis" }	0.9935	0.9861	0.9848	{ "llama3.3": 1, "mistral": 0.9895, "qwen2.5": 0.991 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.744439Z	false	true
d0642f78-a3f8-4840-b1c6-174085953535	oncology	Lymphoma	Oncology Consultation	51	Female	follow_up	{ "category": "Lymphoma", "confidence": 0.9923, "primary": "follow_up" }	0.9923	0.9672	0.9848	{ "llama3.3": 0.9768, "mistral": 1, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.744751Z	false	true
1d181d21-fe5f-4b6a-8e6e-dc3df7bcda3f	oncology	Lung Cancer	Pathology Report	28	Non-binary	prognosis	{ "category": "Lung Cancer", "confidence": 0.975, "primary": "prognosis" }	0.975	0.9502	0.962	{ "llama3.3": 0.987, "mistral": 0.9863, "qwen2.5": 0.9515 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.744932Z	false	true
02aa509d-b21f-4b7a-80f6-17407a2b0cce	oncology	Prostate Cancer	Surgical Note	64	Female	follow_up	{ "category": "Prostate Cancer", "confidence": 0.9768, "primary": "follow_up" }	0.9768	0.9828	0.9617	{ "llama3.3": 0.9692, "mistral": 0.983, "qwen2.5": 0.9782 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.745308Z	false	true
389a461b-f11f-45ba-acc6-4146c8a92ee9	oncology	Breast Cancer	Surgical Note	26	Male	adverse_event	{ "category": "Breast Cancer", "confidence": 0.9777, "primary": "adverse_event" }	0.9777	0.9858	0.9627	{ "llama3.3": 0.9751, "mistral": 0.9736, "qwen2.5": 0.9843 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.745660Z	false	true
3b421c18-715e-4925-9480-8e20197003b0	oncology	Leukemia	Pathology Report	83	Female	treatment_plan	{ "category": "Leukemia", "confidence": 0.99, "primary": "treatment_plan" }	0.99	0.9706	0.9828	{ "llama3.3": 0.9767, "mistral": 0.9933, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.745836Z	false	true
ba7a628a-824d-4f28-bc56-bd1a413433d7	oncology	Breast Cancer	Chemotherapy Order	69	Male	treatment_plan	{ "category": "Breast Cancer", "confidence": 0.9752, "primary": "treatment_plan" }	0.9752	0.98	0.9686	{ "llama3.3": 0.9706, "mistral": 0.9846, "qwen2.5": 0.9703 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.745995Z	false	true
c47856ff-cf2e-49af-80a2-2347d3ac72e9	oncology	Pancreatic Cancer	Surgical Note	57	Female	treatment_plan	{ "category": "Pancreatic Cancer", "confidence": 0.9712, "primary": "treatment_plan" }	0.9712	0.9649	0.9661	{ "llama3.3": 0.9623, "mistral": 0.9636, "qwen2.5": 0.9877 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.746147Z	false	true
b7c175b5-de10-4b0d-a667-c50207fc6f4e	oncology	Pancreatic Cancer	Chemotherapy Order	69	Female	adverse_event	{ "category": "Pancreatic Cancer", "confidence": 0.9766, "primary": "adverse_event" }	0.9766	0.9614	0.9662	{ "llama3.3": 0.9766, "mistral": 0.9923, "qwen2.5": 0.9608 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.746352Z	false	true
a69c5d65-9134-47b7-ace7-b58b2528260f	oncology	Leukemia	Chemotherapy Order	79	Female	follow_up	{ "category": "Leukemia", "confidence": 0.9737, "primary": "follow_up" }	0.9737	0.9805	0.9653	{ "llama3.3": 0.9732, "mistral": 0.966, "qwen2.5": 0.9819 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.746698Z	false	true
37e3ff50-c518-4162-95b8-22f1bf09661c	oncology	Melanoma	Pathology Report	55	Non-binary	diagnosis	{ "category": "Melanoma", "confidence": 0.9771, "primary": "diagnosis" }	0.9771	0.977	0.9667	{ "llama3.3": 0.9878, "mistral": 0.9705, "qwen2.5": 0.973 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.746860Z	false	true
d959d49d-50ca-46e7-9b79-f9164d77f154	oncology	Breast Cancer	Radiation Plan	41	Non-binary	adverse_event	{ "category": "Breast Cancer", "confidence": 0.9802, "primary": "adverse_event" }	0.9802	0.9658	0.9647	{ "llama3.3": 0.9858, "mistral": 0.9905, "qwen2.5": 0.9643 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.747023Z	false	true
0e99a826-a372-40b9-bc00-5d7c19cfe07b	oncology	Lung Cancer	Oncology Consultation	61	Female	diagnosis	{ "category": "Lung Cancer", "confidence": 0.9755, "primary": "diagnosis" }	0.9755	0.9579	0.9578	{ "llama3.3": 0.9592, "mistral": 0.974, "qwen2.5": 0.9934 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.747418Z	false	true
faaeb49d-c7ee-4210-a50e-e8235f856510	oncology	Melanoma	Oncology Consultation	69	Female	staging	{ "category": "Melanoma", "confidence": 0.9829, "primary": "staging" }	0.9829	0.9715	0.9633	{ "llama3.3": 0.9793, "mistral": 0.9734, "qwen2.5": 0.9958 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.747582Z	false	true
63bbc096-6c5b-4075-a726-6fc90dd825e4	oncology	Melanoma	Pathology Report	43	Male	follow_up	{ "category": "Melanoma", "confidence": 0.9828, "primary": "follow_up" }	0.9828	0.9849	0.9645	{ "llama3.3": 0.9811, "mistral": 0.9776, "qwen2.5": 0.9896 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.747737Z	false	true
16b513fb-6949-4ae3-9a54-efa0f5279f00	oncology	Leukemia	Pathology Report	68	Non-binary	adverse_event	{ "category": "Leukemia", "confidence": 0.9867, "primary": "adverse_event" }	0.9867	0.9927	0.9687	{ "llama3.3": 0.9856, "mistral": 0.9844, "qwen2.5": 0.9901 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.748067Z	false	true
8bf0966a-be61-4a5d-bbbe-0b764b7dd3c0	oncology	Pancreatic Cancer	Pathology Report	56	Male	follow_up	{ "category": "Pancreatic Cancer", "confidence": 0.9757, "primary": "follow_up" }	0.9757	0.9634	0.9653	{ "llama3.3": 0.9643, "mistral": 0.9702, "qwen2.5": 0.9926 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.748490Z	false	true
d618d417-4c8c-43d2-b1a4-b1593d176a3c	oncology	Prostate Cancer	Surgical Note	19	Non-binary	adverse_event	{ "category": "Prostate Cancer", "confidence": 0.9842, "primary": "adverse_event" }	0.9842	0.9397	0.9788	{ "llama3.3": 0.9968, "mistral": 0.9559, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.748812Z	false	true
bb85a9e0-1a85-4bac-b9ac-f061e64dcb99	oncology	Pancreatic Cancer	Chemotherapy Order	20	Male	diagnosis	{ "category": "Pancreatic Cancer", "confidence": 0.9809, "primary": "diagnosis" }	0.9809	0.9516	0.9752	{ "llama3.3": 0.9961, "mistral": 0.9585, "qwen2.5": 0.988 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.748971Z	false	true
1e348168-a0c4-43ea-8df6-eeacde2b8cc9	oncology	Prostate Cancer	Pathology Report	77	Male	prognosis	{ "category": "Prostate Cancer", "confidence": 0.9707, "primary": "prognosis" }	0.9707	0.9864	0.9524	{ "llama3.3": 0.9754, "mistral": 0.9646, "qwen2.5": 0.9722 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.749394Z	false	true
f752f952-0c51-4610-b282-793def508bae	oncology	Colorectal Cancer	Oncology Consultation	40	Male	adverse_event	{ "category": "Colorectal Cancer", "confidence": 0.9869, "primary": "adverse_event" }	0.9869	0.981	0.9811	{ "llama3.3": 0.992, "mistral": 0.9906, "qwen2.5": 0.978 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.749566Z	false	true
308cdf23-f213-4d95-98d3-42781ec47ebe	oncology	Pancreatic Cancer	Oncology Consultation	44	Non-binary	prognosis	{ "category": "Pancreatic Cancer", "confidence": 0.9883, "primary": "prognosis" }	0.9883	0.9713	0.9762	{ "llama3.3": 1, "mistral": 0.9884, "qwen2.5": 0.9766 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.749722Z	false	true
11c5aa84-4177-41de-ab12-1e3ebc35cf24	oncology	Lymphoma	Surgical Note	44	Female	treatment_plan	{ "category": "Lymphoma", "confidence": 0.988, "primary": "treatment_plan" }	0.988	0.9744	0.9705	{ "llama3.3": 0.9833, "mistral": 1, "qwen2.5": 0.9807 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.749877Z	false	true
09a41818-67ea-48b6-9a20-664327bf89c6	oncology	Leukemia	Oncology Consultation	82	Non-binary	staging	{ "category": "Leukemia", "confidence": 0.9886, "primary": "staging" }	0.9886	0.9788	0.9763	{ "llama3.3": 0.998, "mistral": 0.981, "qwen2.5": 0.9867 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.750029Z	false	true
03895b46-f883-4d3c-b02b-cfa4b7e43141	oncology	Prostate Cancer	Chemotherapy Order	68	Female	staging	{ "category": "Prostate Cancer", "confidence": 0.9841, "primary": "staging" }	0.9841	0.9583	0.9764	{ "llama3.3": 0.9991, "mistral": 0.9656, "qwen2.5": 0.9876 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.750185Z	false	true
5359b179-c141-4abf-8632-5dcf818ec211	oncology	Lymphoma	Oncology Consultation	68	Non-binary	staging	{ "category": "Lymphoma", "confidence": 0.9798, "primary": "staging" }	0.9798	0.9536	0.9731	{ "llama3.3": 0.9625, "mistral": 1, "qwen2.5": 0.9769 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.750494Z	false	true
f417920c-2270-4b5d-b8fb-bd970f222ccc	oncology	Lung Cancer	Oncology Consultation	42	Male	diagnosis	{ "category": "Lung Cancer", "confidence": 0.9899, "primary": "diagnosis" }	0.9899	0.9876	0.9772	{ "llama3.3": 0.9869, "mistral": 0.9871, "qwen2.5": 0.9958 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.751119Z	false	true
b3fe0d3c-ff0c-4301-a705-8a3f01cf4b2b	oncology	Lung Cancer	Oncology Consultation	54	Female	staging	{ "category": "Lung Cancer", "confidence": 0.9748, "primary": "staging" }	0.9748	0.9503	0.967	{ "llama3.3": 0.9569, "mistral": 0.9968, "qwen2.5": 0.9705 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.751242Z	false	true
d4694573-f8a2-47e5-a098-67d0ea7a895f	oncology	Colorectal Cancer	Surgical Note	53	Male	adverse_event	{ "category": "Colorectal Cancer", "confidence": 0.9747, "primary": "adverse_event" }	0.9747	0.9474	0.957	{ "llama3.3": 0.9767, "mistral": 0.9523, "qwen2.5": 0.995 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.751778Z	false	true
c5d6fd0b-42cc-45ad-a994-a56330cd91a9	oncology	Prostate Cancer	Oncology Consultation	27	Male	prognosis	{ "category": "Prostate Cancer", "confidence": 0.9819, "primary": "prognosis" }	0.9819	0.9839	0.9735	{ "llama3.3": 0.9892, "mistral": 0.98, "qwen2.5": 0.9765 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.751907Z	false	true
35533754-2c50-45dd-880d-9548754af9e4	oncology	Melanoma	Oncology Consultation	36	Non-binary	diagnosis	{ "category": "Melanoma", "confidence": 0.9705, "primary": "diagnosis" }	0.9705	0.9449	0.9598	{ "llama3.3": 0.9524, "mistral": 0.9957, "qwen2.5": 0.9635 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.752350Z	false	true
a4c28ee1-d709-4580-8601-fa6853841234	oncology	Melanoma	Pathology Report	85	Non-binary	diagnosis	{ "category": "Melanoma", "confidence": 0.9781, "primary": "diagnosis" }	0.9781	0.9833	0.9616	{ "llama3.3": 0.9719, "mistral": 0.9769, "qwen2.5": 0.9854 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.752495Z	false	true
bc290966-77aa-4f39-9c52-55941160e3ed	oncology	Breast Cancer	Surgical Note	39	Non-binary	adverse_event	{ "category": "Breast Cancer", "confidence": 0.989, "primary": "adverse_event" }	0.989	0.9765	0.9701	{ "llama3.3": 0.9958, "mistral": 0.9931, "qwen2.5": 0.9781 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.752618Z	false	true
29f31532-bc96-4d77-bebd-24f6b563988a	oncology	Breast Cancer	Chemotherapy Order	45	Non-binary	diagnosis	{ "category": "Breast Cancer", "confidence": 0.984, "primary": "diagnosis" }	0.984	0.9778	0.9729	{ "llama3.3": 0.9769, "mistral": 0.9811, "qwen2.5": 0.9942 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.752863Z	false	true
e69db33c-0bad-400b-9a1f-b52b36d1bfc1	oncology	Pancreatic Cancer	Surgical Note	30	Female	treatment_plan	{ "category": "Pancreatic Cancer", "confidence": 0.9795, "primary": "treatment_plan" }	0.9795	0.971	0.9701	{ "llama3.3": 0.9737, "mistral": 0.9716, "qwen2.5": 0.9931 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.753536Z	false	true
983a6b06-652d-4822-8e87-061c51beba4f	oncology	Melanoma	Chemotherapy Order	27	Non-binary	treatment_plan	{ "category": "Melanoma", "confidence": 0.9788, "primary": "treatment_plan" }	0.9788	0.9853	0.9625	{ "llama3.3": 0.977, "mistral": 0.974, "qwen2.5": 0.9855 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.753658Z	false	true
03084be2-7022-4ea6-8dc9-a1e1834b62e9	oncology	Melanoma	Pathology Report	68	Non-binary	staging	{ "category": "Melanoma", "confidence": 0.971, "primary": "staging" }	0.971	0.9749	0.9524	{ "llama3.3": 0.9784, "mistral": 0.9753, "qwen2.5": 0.9594 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.753789Z	false	true
586d1a6b-d791-4fe3-bc91-624de872db5b	oncology	Prostate Cancer	Oncology Consultation	71	Female	adverse_event	{ "category": "Prostate Cancer", "confidence": 0.9706, "primary": "adverse_event" }	0.9706	0.9725	0.9652	{ "llama3.3": 0.9742, "mistral": 0.9581, "qwen2.5": 0.9796 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.753916Z	false	true
907adf3f-ef32-4794-9aac-f14fff567257	oncology	Colorectal Cancer	Chemotherapy Order	78	Non-binary	staging	{ "category": "Colorectal Cancer", "confidence": 0.9866, "primary": "staging" }	0.9866	0.9952	0.98	{ "llama3.3": 0.9843, "mistral": 0.9874, "qwen2.5": 0.988 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.754034Z	false	true
725b42e8-1a95-4a1b-8b3d-323a0cd7dad7	oncology	Pancreatic Cancer	Radiation Plan	31	Non-binary	treatment_plan	{ "category": "Pancreatic Cancer", "confidence": 0.9724, "primary": "treatment_plan" }	0.9724	0.9781	0.9653	{ "llama3.3": 0.9781, "mistral": 0.962, "qwen2.5": 0.9769 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.754158Z	false	true
8e64dfda-5fe7-448e-b575-2d914b636d39	oncology	Lymphoma	Surgical Note	39	Female	adverse_event	{ "category": "Lymphoma", "confidence": 0.9783, "primary": "adverse_event" }	0.9783	0.9884	0.969	{ "llama3.3": 0.976, "mistral": 0.9751, "qwen2.5": 0.9837 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.754277Z	false	true
8e50a194-4698-4688-8ef2-da200a59d87e	oncology	Pancreatic Cancer	Pathology Report	27	Non-binary	follow_up	{ "category": "Pancreatic Cancer", "confidence": 0.9736, "primary": "follow_up" }	0.9736	0.9809	0.955	{ "llama3.3": 0.9728, "mistral": 0.9663, "qwen2.5": 0.9818 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.754722Z	false	true
ba5a8a76-9c7e-43fe-8632-4e1e4891b580	oncology	Breast Cancer	Chemotherapy Order	69	Female	diagnosis	{ "category": "Breast Cancer", "confidence": 0.9777, "primary": "diagnosis" }	0.9777	0.9768	0.9601	{ "llama3.3": 0.9882, "mistral": 0.9698, "qwen2.5": 0.9752 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.754970Z	false	true
64fb4292-e3f9-4e2b-98ea-4928ffda7c3a	oncology	Lung Cancer	Radiation Plan	20	Non-binary	treatment_plan	{ "category": "Lung Cancer", "confidence": 0.9759, "primary": "treatment_plan" }	0.9759	0.9475	0.9578	{ "llama3.3": 0.9689, "mistral": 1, "qwen2.5": 0.9589 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755088Z	false	true
d419dfa5-cba7-40d8-a59e-11c0ce120b27	oncology	Lymphoma	Surgical Note	51	Non-binary	diagnosis	{ "category": "Lymphoma", "confidence": 0.9928, "primary": "diagnosis" }	0.9928	0.9805	0.975	{ "llama3.3": 0.9941, "mistral": 0.9842, "qwen2.5": 1 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755211Z	false	true
980706fb-9f3a-4a40-91a5-80183f666b7a	oncology	Melanoma	Oncology Consultation	57	Female	staging	{ "category": "Melanoma", "confidence": 0.9928, "primary": "staging" }	0.9928	0.9841	0.9838	{ "llama3.3": 1, "mistral": 0.9908, "qwen2.5": 0.9875 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755339Z	false	true
b1378776-46b2-44d9-b0a6-f867f3d92ec1	oncology	Lymphoma	Radiation Plan	42	Non-binary	diagnosis	{ "category": "Lymphoma", "confidence": 0.9875, "primary": "diagnosis" }	0.9875	0.991	0.9779	{ "llama3.3": 0.9833, "mistral": 0.99, "qwen2.5": 0.9892 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755457Z	false	true
d79514ea-64b0-4207-9082-00ea173b1102	oncology	Melanoma	Pathology Report	45	Female	follow_up	{ "category": "Melanoma", "confidence": 0.9758, "primary": "follow_up" }	0.9758	0.9545	0.9566	{ "llama3.3": 0.9723, "mistral": 0.9592, "qwen2.5": 0.9959 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755659Z	false	true
c687477d-8082-495f-acd5-1da3906a8525	oncology	Lymphoma	Surgical Note	57	Female	staging	{ "category": "Lymphoma", "confidence": 0.9808, "primary": "staging" }	0.9808	0.9771	0.9658	{ "llama3.3": 0.9749, "mistral": 0.9759, "qwen2.5": 0.9915 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.755789Z	false	true
c43f0e8b-f38e-4e64-b068-ce50fa9babca	oncology	Leukemia	Chemotherapy Order	22	Female	prognosis	{ "category": "Leukemia", "confidence": 0.9751, "primary": "prognosis" }	0.9751	0.9828	0.9682	{ "llama3.3": 0.9787, "mistral": 0.9796, "qwen2.5": 0.967 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.756012Z	false	true
82bebd17-530a-42e0-af46-c75acd201125	oncology	Lung Cancer	Surgical Note	72	Non-binary	staging	{ "category": "Lung Cancer", "confidence": 0.987, "primary": "staging" }	0.987	0.9644	0.9756	{ "llama3.3": 0.9713, "mistral": 1, "qwen2.5": 0.9897 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.756208Z	false	true
20e6a3c1-9ffa-409e-9e3a-fc03429212c0	oncology	Breast Cancer	Oncology Consultation	20	Non-binary	treatment_plan	{ "category": "Breast Cancer", "confidence": 0.9748, "primary": "treatment_plan" }	0.9748	0.9911	0.9611	{ "llama3.3": 0.9786, "mistral": 0.9746, "qwen2.5": 0.9713 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.756363Z	false	true
1814d001-c60c-4809-8c8f-892792b2121e	oncology	Leukemia	Surgical Note	34	Female	diagnosis	{ "category": "Leukemia", "confidence": 0.9867, "primary": "diagnosis" }	0.9867	0.9718	0.9745	{ "llama3.3": 0.9735, "mistral": 0.9916, "qwen2.5": 0.9949 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.756611Z	false	true
9530ff1d-f9fd-467d-836f-1b0cf4668434	oncology	Breast Cancer	Pathology Report	67	Female	follow_up	{ "category": "Breast Cancer", "confidence": 0.9792, "primary": "follow_up" }	0.9792	0.9743	0.9669	{ "llama3.3": 0.967, "mistral": 0.9855, "qwen2.5": 0.985 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.756708Z	false	true
6db21b1e-48c8-4e6e-b787-c7b54b4fff6e	oncology	Breast Cancer	Oncology Consultation	46	Female	prognosis	{ "category": "Breast Cancer", "confidence": 0.982, "primary": "prognosis" }	0.982	0.9672	0.9733	{ "llama3.3": 0.9866, "mistral": 0.9669, "qwen2.5": 0.9926 }	true	Trinity_Ensemble_v2	2026-04-10T18:17:57.757007Z	false	true

End of preview. Expand in Data Studio

Oncology Medical Dataset — 1,000 Record Free Sample

Enterprise-grade synthetic medical data. Zero PHI. 100% HIPAA-compliant.

Quality Metrics

Metric	Score	Industry Benchmark
Trinity Consensus Score (TAS)	98.0%	85-92% typical
Inter-Annotator Agreement	0.97	0.75-0.85 typical
Macro F1	0.97	0.80-0.90 typical
PHI Present	None	--
Generation Method	3-LLM Trinity Ensemble	Single model typical

What's Included (Free)

1,000 clinically-structured synthetic oncology records
Full label taxonomy with confidence scores per record
Trinity consensus scores per record (filter by your own threshold)
Structured Parquet format (load with Hugging Face datasets in one line)
Zero PHI -- safe for unrestricted research and commercial use

Quick Start

from datasets import load_dataset

# Load free 1K sample
ds = load_dataset("WitnessDataFactory/oncology-1k", split="train")
print(ds[0])

# Filter by quality gate
high_quality = ds.filter(lambda x: x["consensus_score"] >= 0.97)
print(f"Records passing 97% gate: {len(high_quality)}")

# Export to pandas
df = ds.to_pandas()
df.to_csv("oncology_sample.csv", index=False)

Dataset Schema

{
  "record_id":                  "uuid-v4",
  "domain":                     "oncology",
  "category":                   "Specific clinical subcategory",
  "note_type":                  "Clinical note type",
  "patient_age":                42,
  "patient_gender":             "Female",
  "primary_label":              "diagnosis",
  "labels": {
    "primary":                  "diagnosis",
    "category":                 "Subcategory name",
    "confidence":               0.972
  },
  "consensus_score":            0.972,
  "inter_annotator_agreement":  0.941,
  "macro_f1":                   0.963,
  "model_scores": {
    "llama3.3":                 0.975,
    "mistral":                  0.968,
    "qwen2.5":                  0.972
  },
  "passes_quality_gate":        true,
  "generation_method":          "Trinity_Ensemble_v2",
  "phi_present":                false,
  "hipaa_compliant":            true
}

Upgrade to Production Scale

This 1K sample is your proof-of-concept dataset. When you're ready to train production models:

Tier	Records	Price	Per-Record	Best For	Buy
Starter	10,000	$1,999	$0.20	Pilot deployment, MVP	Buy Now
Production	50,000	$7,999	$0.16	Model training, Series C+	Buy Now
Enterprise	250,000	$29,999	$0.12	FDA-track, clinical AI	Buy Now
Strategic	1,000,000	$99,999	$0.10	Multi-year partnerships	Contact Sales

Multi-Domain Bundles

Bundle	Contents	Price	Discount
3-Domain Bundle	50K x 3 domains of choice	$19,999	17% off
Complete Collection	50K x all 9 specialties	$49,999	22% off

View All Bundles

Delivery: Instant checkout -> Full dataset delivered within 24 hours.

Why WITNESS DATA FACTORY?

Speed

Your research timeline shouldn't wait 3-6 months for custom data generation. Production datasets delivered in under 24 hours from purchase.

Quality

98.0% Trinity consensus vs. 85-92% industry standard
3-LLM ensemble eliminates single-model hallucination bias
Every record validated through Trinity quality gates before delivery
Documented, reproducible QA certificate included with every order

Scale

Proven on 100M+ record PostgreSQL infrastructure
Billion-record architecture ready for enterprise contracts
9 medical domains, 4 volume tiers, instant zero-touch fulfillment

Compliance

Zero PHI -- 100% synthetic, no de-identification liability
HIPAA-compliant by architecture (no real patient data ever ingested)
No IRB required -- fully synthetic generation pipeline
Commercial use permitted under CC BY 4.0 (sample tier)

Citation

@dataset{witness_data_factory_oncology_2026,
  title     = {Oncology Synthetic Medical Dataset},
  author    = {WITNESS DATA FACTORY},
  year      = {2026},
  publisher = {HuggingFace},
  url       = {https://huggingface.co/datasets/WitnessDataFactory/oncology-1k}
}

🛒 Need More Than 1,000 Records?

Production packs from 10,000 to 1,000,000 records are available with the same Trinity QA certification (TAS ≥ 0.97).

Pack	Records	Price
Starter	10,000	$1,999
Production	50,000	$7,999
Enterprise	500,000	$49,999
Factory	1,000,000	$89,999

→ Order instantly at witness-data-factory.onrender.com

Enterprise licensing · Custom domains · Volume pricing available
Contact: WitnessDataFactory@gmail.com

🛒 Need More Than 1,000 Records?

Production packs from 10,000 to 1,000,000 records are available with the same Trinity QA certification (TAS ≥ 0.97).

Pack	Records	Price
Starter	10,000	$1,999
Production	50,000	$7,999
Enterprise	250,000	$29,999
Factory	1,000,000	$99,999

→ Order instantly at witness-data-factory.onrender.com

Enterprise licensing · Custom domains · Volume pricing available

Contact

Channel	Address
Sales and Licensing	WitnessDataFactory@gmail.com
Technical Support	WitnessDataFactory@gmail.com
All Datasets	huggingface.co/WitnessDataFactory
Store	witness-data-factory.onrender.com

Powered by WITNESS DATA FACTORY -- Enterprise Synthetic Medical Data at Scale Trinity Ensemble Pipeline v3.2.1 | Zero PHI | Zero-Touch Fulfillment

Operating Modes

The WITNESS DATA FACTORY™ pipeline supports two operating modes:

Mode	`gate_mode`	`witness_gate_status`	Trinity Active?	ESCALATE Handling
Witness Gate	`witness_gate`	`enabled_for_batch`	Yes	Reviewed by Trinity; PASS records delivered, REJECT excluded
Rules-only	`rules_only`	`disabled_for_batch`	No	Excluded without Trinity review

The operating mode for each batch is recorded in the machine-readable qa_certificate.json delivered with every production batch. The actual delivered row count (records_delivered) may be lower than the requested commercial tier size due to automated QA exclusion and, when enabled, gating decisions.

The QA certificate JSON and delivery manifest JSON are the canonical source of truth for batch accounting. The compliance PDFs are supporting human-readable documents.

Downloads last month: 53